2025
Regeneron Pharmaceuticals's net income per employee
increased
0.08% during fiscal year 2025 compared to
2024.
It represents an increase of
$227.05 from
$292.11 K (in
2024) to
$292.34 K (in
2025).
... See more
2024
Regeneron Pharmaceuticals's net income per employee
decreased
-0.63% during fiscal year 2024 compared to
2023.
It represents a decline of
-$1.84 K from
$293.95 K (in
2023) to
$292.11 K (in
2024).
2023
Regeneron Pharmaceuticals's net income per employee
decreased
-19.7% during fiscal year 2023 compared to
2022.
It represents a decline of
-$72.13 K from
$366.08 K (in
2022) to
$293.95 K (in
2023).
2022
Regeneron Pharmaceuticals's net income per employee
decreased
-53% during fiscal year 2022 compared to
2021.
It represents a decline of
-$412.79 K from
$778.87 K (in
2021) to
$366.08 K (in
2022).
2021
Regeneron Pharmaceuticals's net income per employee
increased
102.25% during fiscal year 2021 compared to
2020.
It represents an increase of
$393.78 K from
$385.09 K (in
2020) to
$778.87 K (in
2021).
2020
Regeneron Pharmaceuticals's net income per employee
increased
47.43% during fiscal year 2020 compared to
2019.
It represents an increase of
$123.88 K from
$261.21 K (in
2019) to
$385.09 K (in
2020).
2019
Regeneron Pharmaceuticals's net income per employee
decreased
-20.92% during fiscal year 2019 compared to
2018.
It represents a decline of
-$69.11 K from
$330.32 K (in
2018) to
$261.21 K (in
2019).
2018
Regeneron Pharmaceuticals's net income per employee
increased
70.88% during fiscal year 2018 compared to
2017.
It represents an increase of
$137.02 K from
$193.31 K (in
2017) to
$330.32 K (in
2018).
2017
Regeneron Pharmaceuticals's net income per employee
increased
16.56% during fiscal year 2017 compared to
2016.
It represents an increase of
$27.47 K from
$165.84 K (in
2016) to
$193.31 K (in
2017).
2016
Regeneron Pharmaceuticals's net income per employee
increased
12.11% during fiscal year 2016 compared to
-.
It represents an increase of
$17.92 K from
$147.92 K (in
2015) to
$165.84 K (in
2016).